3,217 press releases indexed under healthcare.
More than half of new mothers don't fully understand their care plans, while health plan leaders rank member engagement and navigation as a top maternal health priority BALTIMORE, July 14, 2026 /PRNewswire/ -- More communication doesn't necessarily mean better communication for pregnant...
TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specializing in precision-based cannabinoids, today announced positive results from the Phase II LiBBY (Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol) clinical trial evaluating the Company’s proprietary oral cannabinoid formulation for the treatment of agitation in patients with advanced dementia. The results were presented by the LiBBY team at AAIC in London, United Kingdom on July 14, 2026.
Sponsors educational summit of leading pediatric AKI health care experts
CALGARY, Alberta, July 14, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. ( TSX-V: VITA.V ; OTCQB: VTLSF ) (" Vitalist "), is pleased to announce that Company CEO Kalvie Legat and CSO Charles Herman will participate in a virtual fireside chat at the Health, Wellness & Longevity Conference presented by Maxim Group on Wednesday, July 22.
(PR-inside.com) First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth MESA, AZ / ACCESS Newswire / July 14, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major evolution for its popular AI-powered mobile app, Snapshot Recipes, introducing a new freemium model designed to dramatically expand user access while accelerating growth. Download Snapshot Recipes for free now: https://snapshotrecipes.app/get/ Snapshot Recipes empowers users to create instant, personalized recipes by simply snapping a photo of their groceries, open fridge, ingredients, a saved meal image, or even a screenshot from social media. The app instantly delivers chef-inspired recipes with ..
First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth
(PR-inside.com) Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced receipt of a Notice of Award for $5.3 million from the National Institutes on Drug Abuse (NIDA)1 to support the development of its novel MPAR® (Multi-Pill Abuse Resistance) overdose-protection technology, and the lead agent, PF614-MPAR. This marks the third consecutive year of NIDA funding under this award, reflecting sustained institutional confidence in ..
(PR-inside.com) 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026 SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The ..
Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection
ESS has launched ESS Clinical MSP, a Managed Service Provider program that helps K-12 school districts simplify the management of clinical and related services. The program serves as a single point of contact for sourcing licensed specialists, coordinating vendors, tracking credentials...
97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026
Launching in New York, San Francisco, and Los Angeles, SONATA combines deep clinical testing, dedicated physicians, and clinical AI to help members build a fuller picture of their health and take action before disease starts. NEW YORK, July 14, 2026 /PRNewswire/ -- SONATA, offering a...